Partner
Kate handles a diverse portfolio of technologies in the life sciences and biopharmaceutical fields, including diagnostic and therapeutic targets, SNPs, antisense nucleic acids, GMOs, antibody and peptide therapeutics.
Kate has considerable experience of drafting patent applications and developing IP filing strategies in the life sciences field. Kate co-ordinates global patent portfolios for UK universities, spin out companies and international corporations. She has a substantial prosecution practice and is highly experienced in acting before the European Patent Office in prosecution, opposition and appeal matters, including attending oral hearings. She has particular in-depth knowledge of the complex legal issues surrounding the enabling nature of deposited biological material.
Kate regularly provides opinions on the most appropriate ways to protect platform technologies, including performing freedom to operate analysis. She has extensive experience in conducting due diligence, including performing patentability and validity analysis, in respect of pharmaceutical and life sciences technologies.
Kate is a direct entrant to the profession, joining Harrison Goddard Foote in 2000 after graduating from the University of Newcastle-upon-Tyne with a BSc in Genetics and an MSc in Industrial Biotechnology.
She became a partner of the firm in 2009.
VIEW FULL PROFILE
